ACADEMIA
Emergency Approval Push for Shionogi’s COVID Pill Not Profit-Driven: Academic Societies
Two Japanese academic societies issued a proposal earlier this month to prod emergency approval of Shionogi’s COVID-19 pill ensitrelvir. On September 8, they posted a letter to clarify the proposal, saying that it was not intended to benefit the manufacturer…
To read the full story
Related Article
- Academic Societies Urge Japan Govt to Approve Shionogi’s COVID-19 Pill
September 5, 2022
ACADEMIA
- Japan Atherosclerosis Society Proposes 3-Tier Lp(a) Risk Framework
September 16, 2026
- Clinical Value of Lp(a) Unchanged despite Pelacarsen PIII Miss: KOL
September 16, 2026
- Yanagisawa Wins Lasker Award for Unlocking Orexin’s Role in Sleep
September 10, 2026
- Generic Shortage Response Evolves into Wakayama’s 1st Regional Formulary
September 3, 2026
- Japan Cancer Database Initiative Aims to Bolster Trial Environment
August 26, 2026
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…





